New citrate dialysis cuts bleeding risk for critically ill patients
NCT ID NCT03842657
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new way to prevent blood clots in the dialysis machine without using heparin, a blood thinner that can cause dangerous bleeding. The method uses a special fluid with citrate and no calcium, and adds calcium back into the body as needed. The study included 97 critically ill patients with a high risk of bleeding and found the approach to be safe and effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Toulouse
Toulouse, France
-
Montpellier Hospital
Montpellier, France
-
Nimes Hospital
Nîmes, France
-
Pellegrin Hospital
Bordeaux, France
-
Tenon Hospital
Paris, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Dialysis patients may straighten up with In-Chair exercise
- New sponge stops bleeding faster after wisdom tooth extraction
- New toothpaste fights gum disease in 12-Week trial
- Could LVAD patients ditch aspirin? new trial aims to find out
- Eye workouts while on dialysis: a new way to prevent falls?
- Could a clotting booster cut blood loss in ICU patients?